The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Rawcliffe Adrian since year 2005.
The trader's CIK number is 1555851.
At the time of the last reporting, Rawcliffe Adrian was the Chief Executive Officer of Adaptimmune Therapeutics Plc .
(stock ticker symbol ADAP).
See this page for all insider trading activities at Adaptimmune Therapeutics Plc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2020-01-14||ADAP||Adaptimmune Therapeutics Plc||Sale||3,236||5.13||16,616|
|2020-01-06||ADAP||Adaptimmune Therapeutics Plc||Sale||5,900||1.20||7,080|
|2019-01-14||ADAP||Adaptimmune Therapeutics Plc||Sale||3,084||5.37||16,557|
|2018-03-20||ADAP||Adaptimmune Therapeutics Plc||Sale||600,000||1.71||1,026,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rawcliffe Adrian (Chief Executive Officer of Adaptimmune Therapeutics Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.